OBJECTIVES:

To quantify the prevalence of parental vaccine hesitancy (VH) in the United States and examine the association of VH with sociodemographics and childhood influenza vaccination coverage.

METHODS:

A 6-question VH module was included in the 2018 and 2019 National Immunization Survey-Flu, a telephone survey of households with children age 6 months to 17 years.

RESULTS:

The percentage of children having a parent reporting they were “hesitant about childhood shots” was 25.8% in 2018 and 19.5% in 2019. The prevalence of concern about the number of vaccines a child gets at one time impacting the decision to get their child vaccinated was 22.8% in 2018 and 19.1% in 2019; the prevalence of concern about serious, long-term side effects impacting the parent’s decision to get their child vaccinated was 27.3% in 2018 and 21.7% in 2019. Only small differences in VH by sociodemographic variables were found, except for an 11.9 percentage point higher prevalence of “hesitant about childhood shots” and 9.9 percentage point higher prevalence of concerns about serious, long-term side effects among parents of Black compared with white children. In both seasons studied, children of parents reporting they were “hesitant about childhood shots” had 26 percentage points lower influenza vaccination coverage compared with children of parents not reporting hesitancy.

CONCLUSIONS:

One in 5 children in the United States have a parent who is vaccine hesitant, and hesitancy is negatively associated with childhood influenza vaccination. Monitoring VH could help inform immunization programs as they develop and target methods to increase vaccine confidence and vaccination coverage.

What’s Known on This Subject:

Vaccine hesitancy has contributed to large outbreaks of vaccine-preventable diseases in several countries, including the United States.

This is the first report on prevalence of vaccine hesitancy among parents of children 6 months through 17 years in the United States using a survey module developed by Centers for Disease Control and Prevention and examining the association with childhood influenza vaccination coverage.

Vaccine hesitancy (VH) has contributed to large outbreaks of vaccine-preventable diseases in several countries, including the United States.14  Although there is a lack of consensus on the definition of VH, it can be defined as the mental state of holding back in doubt or indecision regarding vaccination.5,6  VH may or may not lead a person to refuse or delay vaccinations for themselves or their children.5,7  Understanding the contributions of VH, among other vaccination barriers, is needed to inform improvements to vaccination programs. Researchers have noted a need for strategies to address VH, including monitoring VH over time by using a standard set of questions at the national level and at a level that allows for analysis of geographic clustering of VH.8,9  In 2018, the National Center for Health Statistics (NCHS) published a set of VH questions developed and tested at the NCHS Questionnaire Design Research Laboratory.10  This set of 6 questions was included in the National Immunization Survey (NIS) family of surveys to evaluate their performance in the field and collect updated information related to parental VH. Our objectives with this study were to quantify national prevalence of parental VH in the United States for children ages 6 months through 17 years, examine sociodemographic variables associated with VH, and examine the association of VH with childhood influenza vaccination coverage. Influenza vaccination coverage remains low and lags behind other childhood vaccines11 ; for the 2018–2019 influenza season, coverage with at least 1 dose was 62.6% among children.12  This article expands on some previous studies of the association of parental VH and child influenza vaccination coverage.1317

During April to June of 2018 and 2019, the NCHS VH module of 6 questions was included in the NIS.20  The NIS is a family of surveys using a national, state-stratified, list-assisted random-digit-dialed cellular telephone sample of households with children in the United States. Households with children aged 19 to 35 months during each calendar quarter of data collection are eligible for the NIS-Child, and households with children aged 13 to 17 years on the date of interview are eligible for the NIS-Teen. During October through June for each influenza season, households with children aged 6 to 18 months or 13 to 17 years not eligible for NIS-Child or NIS-Teen are eligible for a short child influenza module.12  The 1-minute VH module was included on the child influenza module, NIS-Child, and NIS-Teen. Data from these 3 surveys are routinely combined and referred to as the NIS-Flu.12  The response rates ranged across the survey components from 22.8% to 24.4% (2018) and 23.1% to 24.6% (2019). The study sample sizes were n = 36 184 (2018) and n = 39 617 (2019). Because the VH questions were designed to measure VH about all childhood vaccinations, they were placed at a point in the survey immediately after influenza vaccination questions and the following introductory text was added: “The next set of questions are about all recommended childhood vaccines, not just flu vaccination.”

Influenza vaccination status was assessed with the questions: “Since July 1, 2017 [or 2018] has [child] had a flu vaccination? There are two types of flu vaccinations. One is a shot and the other is a spray, mist or drop in the nose.” Sociodemographic characteristics were based on respondent report; the variables included in this study were child’s age and race and ethnicity, household income or poverty level, number of children in the household, mother’s education, urban–rural residence, and the relationship to the child of the person completing the survey. Respondents to the NIS are those who are knowledgeable about the child’s vaccinations. Respondents were predominantly the child’s mother (59.3% in 2018, and 61.6% in 2019), whereas approximately one-third were the child’s father and <10% were another family member. For the purpose of succinctness in this study, we refer to the respondent as the parent.

Proportions of responses to the VH questions were calculated overall and stratified by sociodemographic variables. Adjusted prevalence by each sociodemographic variable was also estimated by using predicted marginals from multivariable logistic regression models including main effects. Adjusted prevalence estimates were similar to unadjusted estimates and are reported in Table 1. For ease of analysis and interpretation, the 4 response categories of the “overall how hesitant are you” question were collapsed into 2 categories, combining “not at all hesitant” and “not that hesitant” responses together and “somewhat” and “very hesitant” responses together. For all 6 questions, a small percentage of respondents said they do not know or did not answer the question; we did not exclude the children of these parents from the analyses because we did not consider these responses to be missing at random given the nature of the hesitancy questions (see Fig 1 footnote for coding details). The recoding did not have an impact on overall results from the small percentages missing (Fig 1). For all sociodemographic variables in the NIS-Flu, except for income, missing responses are routinely imputed during data file processing. There are no missing values for child vaccination status because a completion for the NIS-Flu is defined as completing the survey at least through the vaccination status question.

TABLE 1

Sociodemographic Variables Associated With Parental Prevalence of VH, United States, 2019, NIS-Flu

CharacteristicVH Survey Question, Adjusteda % (95% CI)
Overall, How Hesitant About Childhood Shots Would You Consider Yourself to Be?Is Child Administered Vaccines Following a Standard Schedule, or Some Other Schedule, Such as the Sears Schedule?Did Concerns About the Number of Vaccines Child Gets at One Time Impact Your Decision to Get Child Vaccinated?Did Concern About Serious, Long-Term Side Effects Impact Your Decision to Get Child Vaccinated?Do You Personally Know Anyone Who Has Had a Serious, Long-Term Side Effect From a Vaccine?Is Child’s Doctor or Health Provider Your Most Trusted Source of Information About Childhood Vaccines?
Percentage Reporting Somewhat or Very HesitantPercentage Reporting Some Other SchedulePercentage Reporting YesPercentage Reporting YesPercentage Reporting YesPercentage Reporting No
Child’s age
6–23 mo (referent) 20.3 (18.1–22.4) 6.7 (5.3–8.1) 22.4 (20.2–24.5) 21.9 (19.7–24.2) 12.3 (10.5–14.1) 14.5 (12.4–16.5)
2–4 y 21.1 (19.0–23.2) 7.0 (5.8–8.2) 22.7 (20.5–24.8) 21.8 (19.7–23.8) 13.8 (11.9–15.7) 14.9 (12.9–16.8)
5–12 y 19.9 (18.8–21.0) 6.4 (5.8–7.1) 18.4 (17.4–19.5)* 22.1 (20.9–23.2) 13.0 (12.1–14.0) 14.4 (13.4–15.3)
13–17 y 17.7 (16.4–19.1)* 5.1 (4.3–6.0) 17.3 (16.0–18.7)* 21.0 (19.6–22.4) 14.3 (13.1–15.5) 14.3 (13.1–15.5)
Child’s race and ethnicityb
Non-Hispanic white only (referent) 17.5 (16.4–18.5) 5.9 (5.3–6.6) 18.0 (17.1–19.0) 19.9 (18.9–20.9) 13.6 (12.7–14.5) 14.5 (13.6–15.4)
Non-Hispanic Black only 29.4 (26.6–32.3)* 5.5 (4.2–6.7) 22.1 (19.7–24.4)* 29.8 (27.1–32.5)* 12.4 (10.3–14.6) 15.5 (13.4–17.6)
Hispanic 18.1 (16.3–19.9) 7.1 (5.8–8.3) 19.2 (17.2–21.2) 19.7 (17.8–21.6) 13.5 (11.6–15.4) 13.1 (11.4–14.8)
Non-Hispanic, other or multiple races 18.9 (16.9–20.9) 5.6 (4.5–6.7) 19.8 (17.6–22.1) 24.3 (22.0–26.5)* 13.9 (12.1–15.8) 15.4 (13.2–17.5)
Household income or poverty levelc
Over poverty level, >$75 000/y (referent) 15.9 (14.6–17.2) 5.6 (4.7–6.4) 17.6 (16.2–18.9) 19.0 (17.7–20.3) 13.1 (12.0–14.3) 14.1 (13.1–15.2) Over poverty level, ≤$75 000/y 21.2 (19.7–22.7)* 5.9 (5.1–6.6) 20.2 (18.7–21.7)* 23.1 (21.6–24.7)* 13.8 (12.5–15.2) 15.0 (13.6–16.4)
At or below poverty level 20.8 (18.5–23.1)* 6.3 (5.1–7.5) 18.7 (16.6–20.8) 23.3 (20.9–25.6)* 12.2 (10.4–14.1) 12.6 (10.8–14.4)
Income not reported 25.2 (22.7–27.6)* 8.5 (6.9–10.0)* 22.4 (20.0–24.8)* 25.9 (23.5–28.3)* 15.3 (13.2–17.4) 16.3 (14.2–18.4)
No. children living in the household
1 child (referent) 18.4 (17.0–19.8) 5.4 (4.6–6.2) 19.1 (17.7–20.6) 22.1 (20.6–23.6) 11.8 (10.6–12.9) 13.6 (12.4–14.8)
2 children 19.1 (17.8–20.4) 5.7 (5.0–6.4) 18.4 (17.2–19.6) 20.9 (19.7–22.1) 12.8 (11.8–13.9) 13.5 (12.5–14.6)
3 or more children 20.8 (19.3–22.3)* 7.4 (6.4–8.3)* 19.8 (18.4–21.3) 22.3 (20.9–23.8) 15.8 (14.4–17.3)* 16.4 (15.0–17.7)*
Mother’s education level
Less than high school (referent) 21.0 (18.0–24.0) 6.5 (4.9–8.1) 16.6 (14.2–18.9) 17.6 (15.1–20.1) 9.4 (7.1–11.6) 10.8 (8.8–12.9)
High school or equivalent 22.2 (20.2–24.2) 6.0 (4.9–7.0) 18.6 (16.8–20.5) 23.7 (21.8–25.7)* 12.6 (10.9–14.2)* 11.9 (10.4–13.3)
Some college 21.0 (19.3–22.6) 6.6 (5.6–7.5) 20.1 (18.5–21.8)* 24.3 (22.5–26.0)* 16.2 (14.6–17.8)* 16.0 (14.6–17.5)*
≥ college degree 16.9 (15.8–18.1)* 5.9 (5.1–6.6) 19.3 (18.0–20.6) 20.5 (19.3–21.7) 13.3 (12.3–14.4)* 15.4 (14.2–16.6)*
Who completed the survey?
Child’s mother (referent) 19.8 (18.8–20.8) 5.9 (5.3–6.4) 19.4 (18.4–20.4) 21.6 (20.6–22.6) 14.3 (13.4–15.2) 13.2 (12.3–14.0)
Child’s father 20.0 (18.5–21.6) 6.5 (5.6–7.4) 19.2 (17.7–20.6) 22.9 (21.4–24.4) 11.6 (10.3–12.9)* 16.3 (14.9–17.7)
Other 15.6 (13.3–17.8)* 6.8 (4.9–8.7) 16.2 (13.9–18.5)* 18.5 (16.0–20.9)* 14.2 (11.7–16.8) 17.1 (14.5–19.8)*
Urban–rural residenced
Urban (MSA, central city) (referent) 19.1 (17.6–20.6) 5.9 (5.0–6.7) 19.6 (18.0–21.3) 20.5 (19.0–22.1) 11.8 (10.5–13.1) 14.2 (12.8–15.6)
Suburban (MSA, noncentral city) 19.2 (18.1–20.2) 6.0 (5.4–6.6) 18.7 (17.7–19.6) 22.2 (21.1–23.2) 14.1 (13.1–15.0)* 14.2 (13.3–15.1)
Rural (non-MSA) 21.6 (19.6–23.5)* 7.3 (6.0–8.6) 19.9 (18.1–21.7) 22.0 (20.1–23.9) 13.8 (12.2–15.4) 16.0 (14.4–17.7)
CharacteristicVH Survey Question, Adjusteda % (95% CI)
Overall, How Hesitant About Childhood Shots Would You Consider Yourself to Be?Is Child Administered Vaccines Following a Standard Schedule, or Some Other Schedule, Such as the Sears Schedule?Did Concerns About the Number of Vaccines Child Gets at One Time Impact Your Decision to Get Child Vaccinated?Did Concern About Serious, Long-Term Side Effects Impact Your Decision to Get Child Vaccinated?Do You Personally Know Anyone Who Has Had a Serious, Long-Term Side Effect From a Vaccine?Is Child’s Doctor or Health Provider Your Most Trusted Source of Information About Childhood Vaccines?
Percentage Reporting Somewhat or Very HesitantPercentage Reporting Some Other SchedulePercentage Reporting YesPercentage Reporting YesPercentage Reporting YesPercentage Reporting No
Child’s age
6–23 mo (referent) 20.3 (18.1–22.4) 6.7 (5.3–8.1) 22.4 (20.2–24.5) 21.9 (19.7–24.2) 12.3 (10.5–14.1) 14.5 (12.4–16.5)
2–4 y 21.1 (19.0–23.2) 7.0 (5.8–8.2) 22.7 (20.5–24.8) 21.8 (19.7–23.8) 13.8 (11.9–15.7) 14.9 (12.9–16.8)
5–12 y 19.9 (18.8–21.0) 6.4 (5.8–7.1) 18.4 (17.4–19.5)* 22.1 (20.9–23.2) 13.0 (12.1–14.0) 14.4 (13.4–15.3)
13–17 y 17.7 (16.4–19.1)* 5.1 (4.3–6.0) 17.3 (16.0–18.7)* 21.0 (19.6–22.4) 14.3 (13.1–15.5) 14.3 (13.1–15.5)
Child’s race and ethnicityb
Non-Hispanic white only (referent) 17.5 (16.4–18.5) 5.9 (5.3–6.6) 18.0 (17.1–19.0) 19.9 (18.9–20.9) 13.6 (12.7–14.5) 14.5 (13.6–15.4)
Non-Hispanic Black only 29.4 (26.6–32.3)* 5.5 (4.2–6.7) 22.1 (19.7–24.4)* 29.8 (27.1–32.5)* 12.4 (10.3–14.6) 15.5 (13.4–17.6)
Hispanic 18.1 (16.3–19.9) 7.1 (5.8–8.3) 19.2 (17.2–21.2) 19.7 (17.8–21.6) 13.5 (11.6–15.4) 13.1 (11.4–14.8)
Non-Hispanic, other or multiple races 18.9 (16.9–20.9) 5.6 (4.5–6.7) 19.8 (17.6–22.1) 24.3 (22.0–26.5)* 13.9 (12.1–15.8) 15.4 (13.2–17.5)
Household income or poverty levelc
Over poverty level, >$75 000/y (referent) 15.9 (14.6–17.2) 5.6 (4.7–6.4) 17.6 (16.2–18.9) 19.0 (17.7–20.3) 13.1 (12.0–14.3) 14.1 (13.1–15.2) Over poverty level, ≤$75 000/y 21.2 (19.7–22.7)* 5.9 (5.1–6.6) 20.2 (18.7–21.7)* 23.1 (21.6–24.7)* 13.8 (12.5–15.2) 15.0 (13.6–16.4)
At or below poverty level 20.8 (18.5–23.1)* 6.3 (5.1–7.5) 18.7 (16.6–20.8) 23.3 (20.9–25.6)* 12.2 (10.4–14.1) 12.6 (10.8–14.4)
Income not reported 25.2 (22.7–27.6)* 8.5 (6.9–10.0)* 22.4 (20.0–24.8)* 25.9 (23.5–28.3)* 15.3 (13.2–17.4) 16.3 (14.2–18.4)
No. children living in the household
1 child (referent) 18.4 (17.0–19.8) 5.4 (4.6–6.2) 19.1 (17.7–20.6) 22.1 (20.6–23.6) 11.8 (10.6–12.9) 13.6 (12.4–14.8)
2 children 19.1 (17.8–20.4) 5.7 (5.0–6.4) 18.4 (17.2–19.6) 20.9 (19.7–22.1) 12.8 (11.8–13.9) 13.5 (12.5–14.6)
3 or more children 20.8 (19.3–22.3)* 7.4 (6.4–8.3)* 19.8 (18.4–21.3) 22.3 (20.9–23.8) 15.8 (14.4–17.3)* 16.4 (15.0–17.7)*
Mother’s education level
Less than high school (referent) 21.0 (18.0–24.0) 6.5 (4.9–8.1) 16.6 (14.2–18.9) 17.6 (15.1–20.1) 9.4 (7.1–11.6) 10.8 (8.8–12.9)
High school or equivalent 22.2 (20.2–24.2) 6.0 (4.9–7.0) 18.6 (16.8–20.5) 23.7 (21.8–25.7)* 12.6 (10.9–14.2)* 11.9 (10.4–13.3)
Some college 21.0 (19.3–22.6) 6.6 (5.6–7.5) 20.1 (18.5–21.8)* 24.3 (22.5–26.0)* 16.2 (14.6–17.8)* 16.0 (14.6–17.5)*
≥ college degree 16.9 (15.8–18.1)* 5.9 (5.1–6.6) 19.3 (18.0–20.6) 20.5 (19.3–21.7) 13.3 (12.3–14.4)* 15.4 (14.2–16.6)*
Who completed the survey?
Child’s mother (referent) 19.8 (18.8–20.8) 5.9 (5.3–6.4) 19.4 (18.4–20.4) 21.6 (20.6–22.6) 14.3 (13.4–15.2) 13.2 (12.3–14.0)
Child’s father 20.0 (18.5–21.6) 6.5 (5.6–7.4) 19.2 (17.7–20.6) 22.9 (21.4–24.4) 11.6 (10.3–12.9)* 16.3 (14.9–17.7)
Other 15.6 (13.3–17.8)* 6.8 (4.9–8.7) 16.2 (13.9–18.5)* 18.5 (16.0–20.9)* 14.2 (11.7–16.8) 17.1 (14.5–19.8)*
Urban–rural residenced
Urban (MSA, central city) (referent) 19.1 (17.6–20.6) 5.9 (5.0–6.7) 19.6 (18.0–21.3) 20.5 (19.0–22.1) 11.8 (10.5–13.1) 14.2 (12.8–15.6)
Suburban (MSA, noncentral city) 19.2 (18.1–20.2) 6.0 (5.4–6.6) 18.7 (17.7–19.6) 22.2 (21.1–23.2) 14.1 (13.1–15.0)* 14.2 (13.3–15.1)
Rural (non-MSA) 21.6 (19.6–23.5)* 7.3 (6.0–8.6) 19.9 (18.1–21.7) 22.0 (20.1–23.9) 13.8 (12.2–15.4) 16.0 (14.4–17.7)

MSA, metropolitan statistical area.

a

Adjusted estimates are based on multivariable logistic regression models with the hesitancy question as the dependent variable and the following variables as independent variables: child’s age, child’s race and ethnicity, household income, number of children in the household, mother’s education, respondent relationship to the child, and MSA of residence.

b

Race of child was reported by parent or guardian respondent. Children of Hispanic ethnicity may be of any race. Children identified as multiple races had >1 race category selected.

c

Income and poverty level was defined on the basis of total family income in the past calendar year, and the US Census poverty thresholds for that year specified for the applicable family size and number of children <18 y. Poverty thresholds are available at http://www.census.gov/hhes/www/poverty/data/threshld/index.html.

d

MSA was based on parent or guardian respondent-reported city, state, county, and zip code of residence by using the MSA definition file (https://www.census.gov/programs-surveys/metro-micro.html).

*

Statistically significant at P < .05 in the APD compared with the referent group.

FIGURE 1

Prevalence of VH in the United States among parents of children age 6 months to 17 years, United States, 2018 and 2019, NIS-Flu. The recoding of do not know and refused responses to the 6 questions and their combined prevalence follows, ordered according to presentation in this figure: (1) grouped with nonhesitant (0.7% and 0.7%, for 2018 and 2019, respectively), (2) grouped with “standard schedule” (6.7% and 5.1%), (3) grouped with no concern (1.1% and 0.9%), (4) grouped with no concern (1.0% and 0.8%), (5) grouped with yes (1.1% and 1.0%), (6) grouped with no (1.0% and 1.0%).

FIGURE 1

Prevalence of VH in the United States among parents of children age 6 months to 17 years, United States, 2018 and 2019, NIS-Flu. The recoding of do not know and refused responses to the 6 questions and their combined prevalence follows, ordered according to presentation in this figure: (1) grouped with nonhesitant (0.7% and 0.7%, for 2018 and 2019, respectively), (2) grouped with “standard schedule” (6.7% and 5.1%), (3) grouped with no concern (1.1% and 0.9%), (4) grouped with no concern (1.0% and 0.8%), (5) grouped with yes (1.1% and 1.0%), (6) grouped with no (1.0% and 1.0%).

Close modal

The association of child influenza vaccination coverage with hesitancy variables was tested by using multivariable logistic regression models. One model for each hesitancy variable was run, with the dependent variable being influenza vaccination status and independent variables being the one hesitancy variable and all of the sociodemographic variables. Adjusted prevalence and adjusted prevalence differences (APDs) were calculated from all models with significance tests based on the APDs. As a partial examination of the interrelationship of the 6 hesitancy variables, we stratified responses by the self-reported overall hesitancy question and calculated the prevalence of the other VH questions. All analyses were weighted to population totals and to adjust for households having multiple telephone lines, unit nonresponse, and noncoverage of noncellular-telephone households. A 2-sided significance level of 0.05 was adopted for all statistical tests; comparisons in the text described as different, higher, or lower were statistically significant. Analyses were conducted using SAS, version 9.4 (SAS Institute, Inc, Cary, NC) and SUDAAN (version 11.0.3) to account for the complex survey design.

The percentage of children aged 6 months through 17 years in the United States having a parent who said they were hesitant about childhood shots was 25.8% (7.5% very hesitant and 18.3% somewhat hesitant) in 2018 and 19.5% (5.6% very hesitant and 13.8% somewhat hesitant) in 2019 (Fig 1). In both survey years, 6% of children had a parent reporting using a nonstandard vaccine schedule. The prevalence of concern about the number of vaccines a child gets at one time impacting the parent’s decision to get their child vaccinated was 22.8% in 2018 and 19.1% in 2019, whereas the prevalence of concern about serious, long-term side effects impacting the parent’s decision to get their child vaccinated was 27.3% in 2018 and 21.7% in 2019. The prevalence of personally knowing anyone who has had a serious long-term side effect from a vaccine was 14.9% in 2018 and 13.5% in 2019. Finally, the prevalence of not considering the child’s doctor or health provider as the most trusted source of information about childhood vaccines was 17.3% in 2018 and 14.4% in 2019 (Fig 1).

Responses to the question “overall how hesitant about childhood shots would you consider yourself to be” were strongly associated with responses to the other 5 VH questions (Fig 2). Among children with a parent reporting being somewhat or very hesitant about childhood shots, 63.2% had a parent reporting concerns about serious, long-term side effects impacting their decision to get the child vaccinated, whereas this percentage was 11.7% among those with a parent not at all or not that hesitant. Likewise, the prevalence of the other VH constructs was low but not absent among those self-reporting as not at all or not that hesitant about childhood shots (Fig 2).

FIGURE 2

Association of self-reported hesitancy with other VH questions, United States, 2019, NIS-Flu.

FIGURE 2

Association of self-reported hesitancy with other VH questions, United States, 2019, NIS-Flu.

Close modal

Child’s age was associated with parental self-report of being hesitant about childhood shots; 17.7% of parents of children aged 13 to 17 years compared with 20.3% of parents of children aged 6 to 23 months reported being hesitant (Table 1). The child’s age was also associated with parental concern about the number of vaccines a child gets at one time affecting their decision to vaccinate, with lower prevalence of concern among parents of children aged 5 to 17 years compared with children aged 6 to 23 months (Table 1). Parents of non-Hispanic Black children, compared with parents of non-Hispanic white children, had higher prevalence of self-reported hesitancy about childhood shots (29.4% vs 17.5%), concerns about the number of shots (22.1% vs 18.0%), and concerns about side effects (29.8% vs 19.9%); these are the largest differences in Table 1. Parents of non-Hispanic other or multiple race children also had a higher prevalence of concerns about side effects compared with parents of non-Hispanic white children (24.3% vs 19.9%).

Parents in the highest income group had lower prevalence of self-reported hesitancy about childhood shots than all other income groups (15.9% vs 20.8%–25.2%), and likewise, they had lower prevalence of concern about side effects than all other income groups (19.0% vs 23.1%–25.9%; Table 1). Parents who did not report income on the survey had a higher prevalence of not following the standard schedule compared with the highest income group (8.5% vs 5.6%; Table 1). Compared with there being only 1 child in the household, having ≥3 children living in the household was associated with higher prevalence of hesitancy about childhood shots (20.8% vs 18.4%), using a nonstandard schedule (7.4% vs 5.4%), reporting knowing someone with side effects from vaccines (15.8% vs 11.8%), and the doctor not being the most trusted source for vaccine information (16.4% vs 13.6%; Table 1). Higher mother’s education (college degree) was associated with lower prevalence of self-reported hesitancy compared with mothers with less than a high school degree (16.9% vs 21.0%). However, higher education was generally associated with higher prevalence of concerns about the number of vaccines and side effects as well as reporting personally knowing someone with vaccine side effects and not having the child’s doctor as the most trusted source of information about vaccines (Table 1). Respondents who were not the child’s mother or father had a lower prevalence of self-reported hesitancy. There was a slightly higher prevalence of self-reported hesitancy in rural areas (21.6%) compared with urban areas (19.1%) but no differences on any other VH variable except for a higher prevalence of suburban parents reporting knowing someone affected by side effects compared with urban parents (14.1% vs 11.8%; Table 1).

All 6 VH variables were strongly associated with child influenza vaccination coverage. Adjusted influenza vaccination coverage was 25.8 percentage points lower in the 2017–2018 season and 25.6 percentage points lower in the 2018–2019 season among children of parents who self-reported being somewhat or very hesitant about childhood shots compared with children of parents who were not at all or not that hesitant (Table 2). The APDs in vaccination coverage were of similar magnitude for the other 5 VH variables (Table 2). The APDs in vaccination coverage ranged from 18.1 to 25.8 percentage points across the 2 influenza seasons and the 6 VH variables, thus indicating lower influenza vaccination coverage of children of parents who report elements of VH defined by the 6 survey questions.

TABLE 2

Parental Hesitancy Response Prevalence by Their Child’s Influenza Vaccination Status Subgroup, and Child Influenza Vaccination Coverage by Parental Hesitancy Response, Children Age 6 Months to 17 Years, United States, 2017–2018 and 2018–2019 Influenza Seasons, NIS-Flu

Parental VH Question Responses by Subgroup Defined by Child’s Influenza Vaccination StatusChild’s Influenza Vaccination Coverage (≥1 dose)
2017–2018 Influenza Season2018–2019 Influenza Season2017–2018 Influenza Season2018–2019 Influenza Season
Vaccinated Subgroup, % (95% CI)Unvaccinated Subgroup, % (95% CI)Vaccinated Subgroup, % (95% CI)Unvaccinated Subgroup, % (95% CI)Adjusteda % (95% CI)Adjusted % (95% CI)
Overall, how hesitant about childhood shots would you consider yourself to be?
Somewhat or very hesitant 17.1 (16.1–18.0) 37.5 (36.0–39.1) 12.7 (11.9–13.6) 30.4 (28.9–32.0) 38.2 (36.3–40.1)* 41.4 (39.2–43.6)*
Not at all or not that hesitant 82.9 (82.0–83.9) 62.5 (60.9–64.0) 87.3 (86.4–88.1) 69.6 (68.0–71.1) 63.9 (62.8–65.1)* 67.0 (65.9–68.0)*
APD     −25.8 −25.6
Is child administered vaccines following a standard schedule, or some other schedule, such as the Sears schedule?
Standard schedule 96.2 (95.7–96.6) 90.4 (89.5–91.2) 96.1 (95.6–96.5) 90.3 (89.3–91.2) 58.9 (57.8–59.9)* 63.5 (62.5–64.4)*
Some other schedule 3.8 (3.4–4.3) 9.6 (8.8–10.5) 3.9 (3.5–4.4) 9.7 (8.8–10.7) 34.1 (30.6–37.7)* 39.7 (36.0–43.4)*
APD     24.7 23.7
Did concerns about the number of vaccines child gets at one time impact your decision to get child vaccinated?
Yes 16.6 (15.7–17.5) 31.2 (29.7–32.6) 14.6 (13.8–15.5) 26.3 (24.9–27.7) 41.4 (39.4–43.4)* 47.3 (45.2–49.5)*
No 83.4 (82.5–84.3) 68.8 (67.4–70.3) 85.4 (84.5–86.2) 73.7 (72.3–75.1) 62.0 (60.9–63.1)* 65.4 (64.4–66.5)*
APD     −20.6 −18.1
Did concern about serious, long-term side effects impact your decision to get child vaccinated?
Yes 19.0 (18.1–20.0) 38.3 (36.8–39.8) 14.8 (14.0–15.7) 32.9 (31.4–34.4) 40.6 (38.7–42.4)* 43.2 (41.2–45.2)*
No 81.0 (80.0–81.9) 61.7 (60.2–63.2) 85.2 (84.3–86.0) 67.1 (65.6–68.6) 63.6 (62.4–64.7)* 67.2 (66.2–68.3)*
APD     −23.0 −24.1
Do you personally know anyone who has had a serious, long-term side effect from a vaccine?
Yes 9.5 (8.8–10.3) 22.1 (20.8–23.5) 8.8 (8.1–9.5) 21.2 (19.8–22.5) 37.7 (35.3–40.2)* 41.4 (38.8–44.1)*
No 90.5 (89.7–91.2) 77.9 (76.5–79.2) 91.2 (90.5–91.9) 78.8 (77.5–80.2) 60.7 (59.6–61.8)* 65.2 (64.2–66.2)*
APD     −23.0 −23.8
Is child’s doctor or health provider your most trusted source of information about childhood vaccines?
Yes 87.4 (86.5–88.2) 76.6 (75.1–77.9) 89.3 (88.6–90.0) 79.5 (78.1–80.8) 60.5 (59.4–61.6)* 64.7 (63.7–65.7)*
No 12.6 (11.8–13.5) 23.4 (22.1–24.9) 10.7 (10.0–11.4) 20.5 (19.2–21.9) 41.9 (39.5–44.2)* 45.8 (43.3–48.3)*
APD     18.6 18.9
Parental VH Question Responses by Subgroup Defined by Child’s Influenza Vaccination StatusChild’s Influenza Vaccination Coverage (≥1 dose)
2017–2018 Influenza Season2018–2019 Influenza Season2017–2018 Influenza Season2018–2019 Influenza Season
Vaccinated Subgroup, % (95% CI)Unvaccinated Subgroup, % (95% CI)Vaccinated Subgroup, % (95% CI)Unvaccinated Subgroup, % (95% CI)Adjusteda % (95% CI)Adjusted % (95% CI)
Overall, how hesitant about childhood shots would you consider yourself to be?
Somewhat or very hesitant 17.1 (16.1–18.0) 37.5 (36.0–39.1) 12.7 (11.9–13.6) 30.4 (28.9–32.0) 38.2 (36.3–40.1)* 41.4 (39.2–43.6)*
Not at all or not that hesitant 82.9 (82.0–83.9) 62.5 (60.9–64.0) 87.3 (86.4–88.1) 69.6 (68.0–71.1) 63.9 (62.8–65.1)* 67.0 (65.9–68.0)*
APD     −25.8 −25.6
Is child administered vaccines following a standard schedule, or some other schedule, such as the Sears schedule?
Standard schedule 96.2 (95.7–96.6) 90.4 (89.5–91.2) 96.1 (95.6–96.5) 90.3 (89.3–91.2) 58.9 (57.8–59.9)* 63.5 (62.5–64.4)*
Some other schedule 3.8 (3.4–4.3) 9.6 (8.8–10.5) 3.9 (3.5–4.4) 9.7 (8.8–10.7) 34.1 (30.6–37.7)* 39.7 (36.0–43.4)*
APD     24.7 23.7
Did concerns about the number of vaccines child gets at one time impact your decision to get child vaccinated?
Yes 16.6 (15.7–17.5) 31.2 (29.7–32.6) 14.6 (13.8–15.5) 26.3 (24.9–27.7) 41.4 (39.4–43.4)* 47.3 (45.2–49.5)*
No 83.4 (82.5–84.3) 68.8 (67.4–70.3) 85.4 (84.5–86.2) 73.7 (72.3–75.1) 62.0 (60.9–63.1)* 65.4 (64.4–66.5)*
APD     −20.6 −18.1
Did concern about serious, long-term side effects impact your decision to get child vaccinated?
Yes 19.0 (18.1–20.0) 38.3 (36.8–39.8) 14.8 (14.0–15.7) 32.9 (31.4–34.4) 40.6 (38.7–42.4)* 43.2 (41.2–45.2)*
No 81.0 (80.0–81.9) 61.7 (60.2–63.2) 85.2 (84.3–86.0) 67.1 (65.6–68.6) 63.6 (62.4–64.7)* 67.2 (66.2–68.3)*
APD     −23.0 −24.1
Do you personally know anyone who has had a serious, long-term side effect from a vaccine?
Yes 9.5 (8.8–10.3) 22.1 (20.8–23.5) 8.8 (8.1–9.5) 21.2 (19.8–22.5) 37.7 (35.3–40.2)* 41.4 (38.8–44.1)*
No 90.5 (89.7–91.2) 77.9 (76.5–79.2) 91.2 (90.5–91.9) 78.8 (77.5–80.2) 60.7 (59.6–61.8)* 65.2 (64.2–66.2)*
APD     −23.0 −23.8
Is child’s doctor or health provider your most trusted source of information about childhood vaccines?
Yes 87.4 (86.5–88.2) 76.6 (75.1–77.9) 89.3 (88.6–90.0) 79.5 (78.1–80.8) 60.5 (59.4–61.6)* 64.7 (63.7–65.7)*
No 12.6 (11.8–13.5) 23.4 (22.1–24.9) 10.7 (10.0–11.4) 20.5 (19.2–21.9) 41.9 (39.5–44.2)* 45.8 (43.3–48.3)*
APD     18.6 18.9

a

Adjusted estimates are based on multivariable logistic regression models, 1 model for each hesitancy question included, with vaccination status as the dependent variable and the hesitancy question and the following variables as independent variables to test for the independent effects of the hesitancy question on vaccination status: child’s age, child’s race and ethnicity, household income, number of children in the household, mother’s education, respondent relationship to the child, and metropolitan statistical area of residence (categories of the sociodemographic variables are the same as those in Table 1).

*

Vaccination coverage estimates are significantly different, P < .05, when comparing the 2 groups defined by the hesitancy question responses.

VH varied widely between states according to the 2019 estimates for the “overall how hesitant about childhood shots” question, with prevalence of parents reporting being somewhat or very hesitant ranging from 12.9% (95% confidence interval [CI]: 9.2–17.9) in Vermont to 25.4% (95% CI: 20.7–30.9) in Mississippi. These state-level VH estimates were inversely correlated with the state-level final influenza vaccination coverage estimates published on FluVaxView for the 2018–2019 influenza season (Fig 3).12

FIGURE 3

State-level parental VH and state-level influenza vaccination coverage, cshildren age 6 months to 17 years, United States, 2018–2019 Influenza Season, NIS-Flu.

FIGURE 3

State-level parental VH and state-level influenza vaccination coverage, cshildren age 6 months to 17 years, United States, 2018–2019 Influenza Season, NIS-Flu.

Close modal

Approximately one-fifth of children in the United States had a parent reporting they were hesitant about childhood shots in 2019. Similar prevalence of VH has been found in some other studies but was higher than in a recent US study.2123  The proportion varied between 2018 and 2019, supporting the need to continuously monitor VH, as pointed out in the literature.8,9  The associations shown in this study between the VH variables and child influenza vaccination coverage may suggest a role for reduction in VH in increasing vaccination coverage with influenza.24  However, even among children of parents who reported being vaccine hesitant, 34% to 47% were vaccinated against influenza. The causal relationship between VH and other barriers to vaccination and decision-making is complex. Provider recommendation has been found to be associated with higher child influenza vaccination coverage.25  Resources for providers to help them speak to VH parents are available.2628

We also found an association of state-level estimates of parental VH with state-level child influenza vaccination coverage. As shown in the literature, there are geographical pockets of VH.4  The association of state-level parental hesitancy variables with vaccination coverage could be an avenue for future study, taking into account possible confounding and state-level vaccination program variables. Although we could not reliably estimate levels of local area VH in this study, the fact that the state-level estimates of VH show variability and association with vaccination coverage suggests that it could be worth exploring variability across smaller geographic areas as well as to identify differences in vaccine confidence at a more granular level.

Although many of the sociodemographic variables showed some group differences for the 6 VH questions, most were small differences but statistically significant because of our large sample size. The exceptions to the small differences were the substantially higher prevalence of hesitancy about childhood shots (11.9 percentage points) and prevalence of self-reported concerns about serious, long-term side effects (9.9 percentage points) among parents of Black compared with white children. Racial disparities in influenza vaccination coverage have long persisted in the United States, among both adults and children.29,30  Early studies of reasons for nonvaccination showed racial differences in belief in misinformation, such as the influenza vaccination causing influenza.16

Examining the interrelationship of the 6 VH module variables emphasized the complexity of the VH construct. For the most part, parents who self-identified as being “hesitant about childhood shots” selected responses indicating aspects of VH for the other 5 questions. Yet there were parents who did not self-identify as being “hesitant about childhood shots” but did have concerns about vaccines, used alternate vaccine schedules, and did not consider their child’s doctor as the most trusted source of information. This is consistent with the findings from the cognitive evaluation of these questions, in which parents’ interpretation of the term “hesitant” related to their overall perception of the benefits and/or risks of childhood vaccination.10  Thus, although a parent may indicate they have specific concerns in regard to vaccines (ie, the number of vaccines their child receives at once), they might still weigh the benefits of vaccination as greater than the risks and thus not identify as vaccine hesitant.

This study is subject to several limitations. Influenza vaccination was parent-reported so there may be reporting bias; authors of some studies have shown that parents over-report child influenza vaccination coverage.30,31  There may be an upward bias in parents reporting they know someone personally who has had a serious, long-term side effect from a vaccine, because serious side effects are rare according to vaccine safety data.32  The survey weighting adjustments may not eliminate all bias from using incomplete sample frames that excluded households with no telephones or only landline telephones. The response rate for the survey was low; hesitancy prevalence and vaccination coverage may differ between respondents and nonrespondents, and survey weighting may not adequately control for these differences. The VH module questions were not influenza-specific but referred to all vaccines; parents may be hesitant about some vaccines more than others.33  Researchers of future studies with the NIS data can examine the association of VH with receipt of childhood vaccines other than influenza. In this study, we did not examine the interaction of VH with other barriers to vaccination such as cost, access-to-care, or lack of convenience.

One in 5 children in the United States have a vaccine hesitant parent, and VH has a strong negative association with childhood influenza vaccination coverage. Consistently monitoring changes in VH, including socioeconomic differences in VH, could inform immunization programs in targeting interventions, provide resources to facilitate provider-patient vaccine conversations, and ultimately increase confidence in vaccinations and improve vaccination coverage to protect children from disease.

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

Dr Santibanez made substantial contributions to the conception and design, analyses, and interpretation of the data and drafting of the article; Drs Nguyen, Srivastav, and Bhatt made substantial contributions to the interpretation of the data; Drs Scanlon, Greby, Singleton, and Ms Fisher made substantial contributions to the acquisition and interpretation of the data; and all authors revised the article critically for intellectual content, approved the final version to be published, and agree to be accountable for all aspects of the work.

FUNDING: No external funding.

ASD

CI

confidence interval

NCHS

National Center for Health Statistics

NIS

National Immunization Survey

VH

vaccine hesitancy

1
Coombes
R
.
Europe steps up action against vaccine hesitancy as measles outbreaks continue
.
BMJ
.
2017
;
359
:
j4803
2
Quinn
SC
,
Jamison
AM
,
Freimuth
VS
.
Measles outbreaks and public attitudes towards vaccine exemptions: some cautions and strategies for addressing vaccine hesitancy
.
Hum Vaccin Immunother
.
2020
;
16
(
5
):
1050
1054
3
McDonald
R
,
Ruppert
PS
,
Souto
M
, et al
.
Notes from the field: measles outbreaks from imported cases in orthodox Jewish communities - New York and New Jersey, 2018–2019
.
MMWR Morb Mortal Wkly Rep
.
2019
;
68
(
19
):
444
445
4
Patel
M
,
Lee
,
Clemmons
NS
, et al
.
National update on measles cases and outbreaks - United States, January 1–October 1, 2019
.
MMWR Morb Mortal Wkly Rep
.
2019
;
68
(
40
):
893
896
5
Bedford
H
,
Attwell
K
,
Danchin
M
,
Marshall
H
,
Corben
P
,
J
.
Vaccine hesitancy, refusal and access barriers: the need for clarity in terminology
.
Vaccine
.
2018
;
36
(
44
):
6556
6558
6.
Merriam-Webster
Dictionary
. Available at: https://www.merriam-webster.com/dictionary/hesitant. Accessed February 10, 2020
7
Enkel
SL
,
Attwell
K
,
Snelling
TL
,
Christian
HE
.
‘Hesitant compliers’: qualitative analysis of concerned fully-vaccinating parents
.
Vaccine
.
2018
;
36
(
44
):
6459
6463
8
Salmon
DA
,
Dudley
MZ
,
Glanz
JM
,
Omer
SB
.
Vaccine hesitancy: causes, consequences, and a call to action
.
Vaccine
.
2015
;
33
(
suppl 4
):
D66
D71
9
WHO
. Improving vaccination demand and addressing hesitancy. 2019. Available at: https://www.who.int/immunization/programmes_systems/vaccine_hesitancy/en/. Accessed February 7, 2020
10
Scanlon
P
,
Jamoom
E
.
The Cognitive Evaluation of Survey Items Related to Vaccine Hesitance and Confidence for Inclusion on a Series of Short Question Sets
.
Hyattsville, MD
:
NCHS
;
2019
11
Hill
HA
,
Singleton
JA
,
Yankey
D
,
Elam-Evans
LD
,
Pingali
SC
,
Kang
Y
.
Vaccination coverage by age 24 Months among children born in 2015 and 2016 - national immunization survey-child, United States, 2016–2018
.
MMWR Morb Mortal Wkly Rep
.
2019
;
68
(
41
):
913
918
12.
Centers for Disease Control and Prevention
.
FluVaxView, influenza vaccination coverage.
2019
. Available at: https://www.cdc.gov/flu/fluvaxview/index.htm. Accessed April 30, 2020
13
Goss
MD
,
Temte
JL
,
Barlow
S
, et al
.
An assessment of parental knowledge, attitudes, and beliefs regarding influenza vaccination
.
Vaccine
.
2020
;
38
(
6
):
1565
1571
14
Lama
Y
,
Hancock
GR
,
Freimuth
VS
,
Jamison
AM
,
Quinn
SC
.
Using classification and regression tree analysis to explore parental influenza vaccine decisions
.
Vaccine
.
2020
;
38
(
5
):
1032
1039
15
Paterson
P
,
Chantler
T
,
Larson
HJ
.
Reasons for non-vaccination: parental vaccine hesitancy and the childhood influenza vaccination school pilot programme in England
.
Vaccine
.
2018
;
36
(
36
):
5397
5401
16
Santibanez
TA
,
Kennedy
ED
.
Reasons given for not receiving an influenza vaccination, 2011-12 influenza season, United States
.
Vaccine
.
2016
;
34
(
24
):
2671
2678
17
Quinn
SC
,
Jamison
AM
,
An
J
,
Hancock
GR
,
Freimuth
VS
.
Measuring vaccine hesitancy, confidence, trust and flu vaccine uptake: results of a national survey of White and African American adults
.
Vaccine
.
2019
;
37
(
9
):
1168
1173
18
Opel
DJ
,
Mangione-Smith
R
,
Taylor
JA
, et al
.
Development of a survey to identify vaccine-hesitant parents: the parent attitudes about childhood vaccines survey
.
Hum Vaccin
.
2011
;
7
(
4
):
419
425
19
Miller
K
,
Willson
S
,
Chep
V
,
JL
.
Cognitive Interviewing Methodology
.
Hoboken, NJ
:
Wiley and Sons
;
2014
20.
Centers for Disease Control and Prevention
. About the National Immunization Surveys (NIS).
2019
. Available at: https://www.cdc.gov/vaccines/imz-managers/nis/about.html. Accessed April 30, 2020
21
A
,
van Esso
D
,
Del Torso
S
, et al
.
Vaccine confidence among parents: large scale study in eighteen European countries
.
Vaccine
.
2020
;
38
(
6
):
1505
1512
22
Opel
DJ
,
Taylor
JA
,
Zhou
C
,
Catz
S
,
Myaing
M
,
Mangione-Smith
R
.
The relationship between parent attitudes about childhood vaccines survey scores and future child immunization status: a validation study
.
JAMA Pediatr
.
2013
;
167
(
11
):
1065
1071
23
Kempe
A
,
Saville
AW
,
Albertin
C
, et al
.
Parental hesitancy about routine childhood and influenza vaccinations: a national survey
.
Pediatrics
.
2020
;
146
(
1
):
e20193852
24
Hofstetter
AM
,
Simon
TD
,
Lepere
K
, et al
.
Parental vaccine hesitancy and declination of influenza vaccination among hospitalized children
.
Hosp Pediatr
.
2018
;
8
(
10
):
628
635
25
Kahn
KE
,
Santibanez
TA
,
Zhai
Y
,
Bridges
CB
.
Association between provider recommendation and influenza vaccination status among children
.
Vaccine
.
2018
;
36
(
24
):
3486
3497
26
Shen
SC
,
Dubey
V
.
Addressing vaccine hesitancy: clinical guidance for primary care physicians working with parents
.
Can Fam Physician
.
2019
;
65
(
3
):
175
181
27
Centers for Disease Control and Prevention
. Provider resources for vaccine conversations with parents. 2020. Available at: https://www.cdc.gov/vaccines/partners/childhood/professionals.html. Accessed February 7, 2020
28
Centers for Disease Control and Prevention
. Vaccinate with confidence. 2020. Available at: https://www.cdc.gov/vaccines/partners/vaccinate-with-confidence.html. Accessed February 7, 2020
29
Lu
PJ
,
O’Halloran
A
,
Bryan
L
, et al
.
Trends in racial/ethnic disparities in influenza vaccination coverage among adults during the 2007–08 through 2011–12 seasons
.
Am J Infect Control
.
2014
;
42
(
7
):
763
769
30
Santibanez
TA
,
Grohskopf
LA
,
Zhai
Y
,
Kahn
KE
.
Complete influenza vaccination trends for children six to twenty-three months
.
Pediatrics
.
2016
;
137
(
3
):
e20153280
31
Brown
C
,
Clayton-Boswell
H
,
Chaves
SS
, et al.;
New Vaccine Surveillance Network (NVSN)
.
Validity of parental report of influenza vaccination in young children seeking medical care
.
Vaccine
.
2011
;
29
(
51
):
9488
9492
32
Centers for Disease Control and Prevention
. Safety information by vaccine. 2020. Available at: https://www.cdc.gov/vaccinesafety/vaccines/index.html. Accessed February 10, 2020
33
Siddiqui
M
,
Salmon
DA
,
Omer
SB
.
Epidemiology of vaccine hesitancy in the United States
.
Hum Vaccin Immunother
.
2013
;
9
(
12
):
2643
2648

## Competing Interests

POTENTIAL CONFLICT OF INTEREST: The authors have indicated they have no potential conflicts of interest to disclose.

FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.